298. Hereditary pancreatitis Clinical trials / Disease details


Clinical trials : 98 Drugs : 180 - (DrugBank : 57) / Drug target genes : 53 - Drug target pathways : 142

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00630279
(ClinicalTrials.gov)
February 200822/2/2008Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisA Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisPancreatic Exocrine Insufficiency Due to Chronic PancreatitisDrug: Placebo;Drug: Recombinant Microbial Lipase SLV339Solvay PharmaceuticalsNULLTerminated18 YearsN/ABoth56Phase 2Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden